Officer and Director Transaction Report

Sigfrido Delgado, SVP of Operations at AVANOS MEDICAL, INC., reported a transaction on March 13, 2026. Delgado acquired 15,886 shares of Common Stock under a time-based restricted share unit (TRSU) award, which will vest over three years starting March 13, 2027. Additionally, Delgado was granted an employee stock option to buy 37,520 shares of Common Stock, with an exercise price of $13.69 and an expiration date of March 13, 2036. This option award will vest in stages, with 30% vesting on March 13, 2027, 30% on March 13, 2028, and 40% on March 13, 2029. Following these transactions, Delgado directly owns 60,005 shares of Common Stock and holds options for an additional 59,434 shares.